RecallDepth
Class II Ongoing

8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1 mEq/mL), 25 x 50 mL Single Dose Vials per carton, For Intravenous Use Only, Rx Only, Manufactured by: Exela Pharma Sciences, LLC, Lenoir, NC 28645. NDC Inner Vial: 51754-5001-1; NDC Carton: 51754-5001-4

This recall is currently active, issued April 2, 2025. It was issued by Exela Pharma Sciences Llc.

Company
Exela Pharma Sciences Llc
Recall Initiated
March 7, 2025
Posted
April 2, 2025
Recall Number
D-0303-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
103,950 vials
Firm Location
Lenoir, NC, United States
Official Source
View on FDA website ↗

Reason for Recall

Lack of Assurance of Sterility

Distribution

Nationwide

Lot / Code Info

Lots: 10006417 and 10006418, Exp. 11/30/2026

More recalls by Exela Pharma Sciences Llc

View all recalls by this company →

Other recent Class II Drug recalls